GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Preferred Dividends

BITGF (Biotage AB) Preferred Dividends : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Biotage AB's preferred dividends for the three months ended in Dec. 2024 was $0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.


Biotage AB Preferred Dividends Historical Data

The historical data trend for Biotage AB's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Preferred Dividends Chart

Biotage AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotage AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotage AB Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Biotage AB  (OTCPK:BITGF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines

From GuruFocus

Biotage AB (publ) Interim report January - June 2021

By PRNewswire PRNewswire 07-16-2021

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022

Biotage AB (publ) Interim report January-September 2020

By PRNewswire PRNewswire 11-05-2020

Q3 2024 Biotage AB Earnings Call Transcript

By GuruFocus News 10-24-2024

Biotage moves to the large cap segment

By PRNewswire PRNewswire 01-03-2022

New capacity helps eliminate bottleneck for COVID-19 vaccines

By PRNewswire PRNewswire 08-16-2021

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) Year-End report January - December 2020

By PRNewswire PRNewswire 02-12-2021

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021